News Search Results
Aug 04, 2026, 09:00 ET PM360 Announces 2026 Lifetime Achievement Award Honoree, CMO of the Year, and Brand Champions
CorporationNephrology/UrologySamantha Meyers, Sr. Director of Digital Strategy, Bayer PharmaceuticalsOphthalmology/OptometryMatt Gibson, Senior Director of Marketing, Interventional Dry Eye, Sight SciencesOphthalmology/OptometryLisa Jensen, Senior Director, Global Marketing - Corneal Health, Glaukos
More news about: PM360
Aug 04, 2026, 09:00 ET New Real-World Data Shows AEYE-DS Autonomous AI Achieving a 96% Success Rate (Imageability) Without Dilation in a High-Traffic Endocrinology Clinic
study in the British Journal of Ophthalmology. The prospective, real-world study demonstrates that the AEYE Diagnostic Screening (AEYE-DS) system integrates into busy endocrinology workflows,
More news about: AEYE Health
Aug 04, 2026, 05:08 ET Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
Aug 04, 2026, 04:51 ET Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
Aug 03, 2026, 07:30 ET Keenova Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Manuscript in Translational Andrology and Urology
diversified brands portfolio, which is focused across a wide range of specialty therapeutic areas of significant unmet need. These include rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology, and neonatal respiratory critical care.Headquartered in Dublin, Ireland, Keenova
More news about: Keenova Therapeutics
Aug 02, 2026, 10:01 ET New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
such therapies. The company's broad therapeutic portfolio currently includes novel agents in oncology, haematology, CNS, neurology, endocrinology, ophthalmology and supportive care, although it is not confined to these areas. Additional information can be found at
More news about: Specialised Therapeutics
Jul 31, 2026, 09:30 ET CU Anschutz Physicians Recognized Among Colorado's Top Doctors for 2026
Malik Kahook, MD, Ophthalmology: Kahook is an internationally recognized glaucoma specialist,
More news about: University of Colorado Anschutz
Jul 31, 2026, 09:13 ET Cornea Transplant Specialist Mohammad Dastjerdi, MD, Joins NYU Langone Eye Center
teaching awards from ophthalmology residents and has mentored resident cataract surgery training for over a decade. He serves as cornea/external disease section editor for Survey of Ophthalmology and as an examiner and committee member for the American Board of Ophthalmology. He has published more
More news about: NYU Langone Health
Jul 30, 2026, 16:05 ET Castle Biosciences Reports Second Quarter 2026 Results
the New York State Department of Health (NYSDOH). With this approval, Castle has New York State approval for all tests within its dermatology and ophthalmology portfolios, its TissueCypher test within gastroenterology and its clinical laboratories in Phoenix and Pittsburgh. See the Company's
More news about: Castle Biosciences, Inc.
Jul 30, 2026, 09:00 ET Roche announces partnership with Ivy Tech to help strengthen Indiana's medical laboratory workforce
Across its Diagnostics and Pharmaceutical divisions, Roche focuses on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases and immunology with the aim of providing real and positive change for patients, the people they love and the professionals
More news about: Roche
Jul 30, 2026, 07:00 ET Keenova Therapeutics to Report Second Quarter 2026 Financial Results on August 11, 2026
diversified brands portfolio, which is focused across a wide range of specialty therapeutic areas of significant unmet need. These include rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology, and neonatal respiratory critical care.Headquartered in Dublin, Ireland, Keenova
More news about: Keenova Therapeutics
Jul 29, 2026, 15:38 ET Piramal Pharma Limited Announces Results for Q1 FY27
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Limited
Jul 29, 2026, 15:27 ET Piramal Pharma Limited Announces Results for Q1 FY27
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Limited
Jul 29, 2026, 13:14 ET GMP Biologics Market to Reach US$98.2 Bn by 2033 Accelerates with Biopharmaceutical Innovation - Persistence Market Research
Recombinant Proteins, Vaccines, Insulin, Interferons, Growth Factors, Others), by Therapeutic Area (Oncology, Autoimmune Disease, Metabolic Disease, Ophthalmology, Cardiovascular Disease, Infectious Disease, Neurology, Respiratory Disorder, Others), by Application (Hybrid Electric Vehicles, Consumer Electronics,
More news about: Persistence Market Research Pvt. Ltd.
Jul 28, 2026, 10:15 ET Antibody Therapeutics Market worth $597.1 billion by 2035 - Exclusive Report by MarketsandMarkets™
care centers segment is attributed to the increasing use of antibody therapeutics across oncology, autoimmune diseases, inflammatory disorders, ophthalmology, and rare diseases. These facilities play a critical role in administering complex biologics such as monoclonal antibodies, bispecific antibodies,
More news about: MarketsandMarkets
Jul 27, 2026, 11:14 ET Everest Medicines Announces Participation in Upcoming Investor Conferences
extensive track record both in China and with leading global pharmaceutical companies. The Company's therapeutic areas of focus include autoimmune, ophthalmology, critical care, and CKM (cardiovascular, kidney, and metabolic) diseases. Everest Medicines has developed a fully integrated commercialization platform
More news about: Everest Medicines
Jul 24, 2026, 08:30 ET Roche receives FDA clearance for the cobas® BV/CV assay, enabling fast and highly accurate vaginitis diagnosis
Across its Diagnostics and Pharmaceutical divisions, Roche focuses on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases and immunology with the aim of providing real and positive change for patients, the people they love and the professionals
More news about: Roche
Jul 23, 2026, 12:00 ET Dr. Atul Kakkar Joins OCLI Vision in Floral Park, Massapequa and Woodbury
Institute of Medical Sciences in India and completed his ophthalmology residency at Dayanand Medical College and Hospital. He is ECFMG-certified and further advanced his subspecialty training through a prestigious fellowship in pediatric ophthalmology and adult strabismus at the internationally renowned
More news about: OCLI Vision
Jul 23, 2026, 10:00 ET Georgia Vision Institute Partners with Switchboard, MD to Streamline Patient Communication & Referral Operations
unified view of patient communication across every channel.About Georgia Vision InstituteGeorgia Vision Institute is a leading ophthalmology practice serving West Georgia and East Alabama. The organization operates four clinic locations and one ambulatory surgery center, with a team of
More news about: Switchboard, MD
Jul 22, 2026, 10:23 ET Global Indocyanine Green Market to Exceed USD 380 Million by 2031, Growing at a CAGR of 13.26% - Exclusive Insights by Arizton
clinical decision-making and personalized treatment strategies. This growing reliance on high-resolution retinal imaging continues to strengthen ophthalmology as a key application area for the ICG market.North America Leads the Global Shift Toward Fluorescence-Guided SurgeryNorth America
More news about: Arizton Advisory & Intelligence
Jul 22, 2026, 09:00 ET Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges
Across its Diagnostics and Pharmaceutical divisions, Roche focuses on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases and immunology with the aim of providing real and positive change for patients, the people they love and the professionals
More news about: Roche
Jul 21, 2026, 17:30 ET Top 10 Medical Device Technologies Market worth $829.69 billion by 2031 - Exclusive Report by MarketsandMarkets™
2025.By type, the top 10 medical devices market comprises in vitro diagnostic devices, cardiovascular devices, imaging devices, orthopedic devices, ophthalmology devices, endoscopy devices, diabetes care devices, wound care devices, kidney/dialysis devices, and respiratory care devices. Among these, the in
More news about: MarketsandMarkets
Jul 21, 2026, 09:00 ET Luminopia Teams Up with Spin Master to Bring Popular Children's Programming to Pediatric Amblyopia Treatment
results were published in Ophthalmology, leading to the initial FDA clearance for patients aged 4 to 7 years. Based on the robust real-world evidence collected through the PUPiL Registry,
More news about: Luminopia
Jul 20, 2026, 08:20 ET Roche Appoints Dan Malarek as President and CEO of Roche Diagnostics North America
Across its Diagnostics and Pharmaceutical divisions, Roche focuses on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases and immunology with the aim of providing real and positive change for patients, the people they love and the professionals
More news about: Roche
Jul 18, 2026, 14:55 ET REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
com 1Singer MA, et al. Ophthalmology. 2012;119(6):1175-83. 2 Silva R, et al. Ophthalmology. 2012;120,130-39.; 3Maguire MG, et al. Ophthalmology. 2016;123, 1751-61. 4Khanani A, et al. Ophthalmology. 2019;4(2):122-33. 5Ciulla
More news about: REGENXBIO Inc.